Faculty Opinions recommendation of Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study).
2014 ◽
Vol 73
(7)
◽
pp. 1393-1396
◽
2013 ◽
Vol 72
(Suppl 3)
◽
pp. A89.2-A89
◽
2015 ◽
Vol 26
(1)
◽
pp. 156-158
◽
2016 ◽
Vol 75
(Suppl 2)
◽
pp. 774.1-774
2017 ◽
2013 ◽
Vol 71
(Suppl 3)
◽
pp. 639.12-639